Skip to main content

Syndicate contentColumbia University

NEJM study points to new era in hepatitis C treatment

NEW YORK (June 4, 2009) -- For patients with the most common form of hepatitis C, the addition of a hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.

NewYork-Presbyterian/Columbia physician-scientists present at 2009 American Transplant Congress

NEW YORK (June 4, 2009) -- NewYork-Presbyterian Hospital/Columbia University Medical Center physician-scientists presented new research at the 2009 American Transplant Congress in Boston, May 30 to June 3. Topics included minimizing steroid exposure for liver transplant patients with hepatitis C; hypothermic machine perfusion vs.

NEJM study finds radiofrequency ablation can reverse Barrett's esophagus, reduce cancer risk

NEW YORK (May 29, 2009) -- Patients who have gastroesophageal reflux disease (GERD) for a prolonged period have an increased risk of developing Barrett's esophagus, a pre-cancerous condition where the tissue lining the esophagus becomes damaged by stomach acid and transformed into something like the inside of the stomach.

New arenavirus discovered as cause of hemorrhagic fever outbreak in South Africa and Zambia

May 28, 2009 -- Scientists at Columbia University's Mailman School of Public Health, the South African National Institute for Communicable Diseases of National Health Laboratory Service (NICD-NHLS), the U.S.

New mouse model of depression/anxiety enhances understanding of antidepressant drugs

A recent study finds that the antidepressant effects of drugs like Prozac involve both neurogenesis-dependent and -independent mechanisms, a finding that may lead to development of better treatments for depression and anxiety.

Results of phase I trial of novel herbal therapy for men at high risk of prostate cancer

NEW YORK ? Results of a phase I clinical trial of a novel herb-based therapeutic called Zyflamend have demonstrated that the therapy is associated with minimal toxicity and no serious adverse events in men at high-risk for developing prostate cancer.

Early exposure to tobacco smoke may lead to early emphysema later

ATS 2009, SAN DIEGO? Chronic exposure to tobacco smoke in childhood may contribute to early emphysema later in life, according to new research. Environmental tobacco smoke (ETS) is known to be associated with a variety of serious health problems, but it had not previously been associated with the development of emphysema over the life course.

Feeling cramped while shopping? Variety provides relief

When consumers find themselves in stores with narrow aisles, they react in a surprising way: they seek variety. According to a new study in the Journal of Consumer Research, confined spaces might help people diversify their choices.

Terrorist attacks provoke surge in alcohol and drug use

Nearly one in 12 people exposed to terrorism report increased use and misuse of alcohol, according to researchers at Columbia University Mailman School of Public Health and the University of Michigan.

Drug-eluting stents prove more effective, equally as safe as bare-metal stents

NEW YORK, NY - MAY 6, 2009 - The Cardiovascular Research Foundation (CRF) announced that its landmark study comparing the safety and efficacy of drug-eluting stents and bare-metal stents was published today in The New England Journal of Medicine.

Research at Columbia University Medical Center shows why certain arterial plaques can turn deadly

NEW YORK (May 5, 2009) - A common misconception about arterial plaque is that it inevitably leads to a heart attack or a stroke. New research at Columbia University Medical Center, however, sheds light on why so few plaques in any given individual actually cause a problem.

Why parents miss their children's immunization visits

BALTIMORE -- According to a new study led by researchers at Columbia University Medical Center and NewYork-Presbyterian Hospital, there are several factors that contribute to children missing immunization visits.

The findings will be reported in a platform presentation at 8:30 a.m. ET on Tuesday, May 5, 2009, at the Pediatric Academic Societies (PAS) annual meeting here.

Brain protein central to both Parkinson's, drug addiction identified

NEW YORK, May 4, 2009 - Scientists have identified a protein that appears not only to be central to the process that causes Parkinson's disease but could also play a role in muting the high from methamphetamine and other addictive drugs.

Brain protein central to both Parkinson's, drug addiction identified

Scientists have identified a protein that appears not only to be central to the process that causes Parkinson's disease but could also play a role in muting the high from methamphetamine and other addictive drugs.

Combination of genetic and environmental 'hits' required for Parkinson's disease

New research finds that a complex interaction between separate factors underlies the pathology associated with Parkinson's disease (PD), reinforcing the concept that multiple therapeutic targets should be considered when designing treatment strategies.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes